paclitaxel has been researched along with Carcinoma, Acinar Cell in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Cao, D; Hu, Q; Wang, X; Xu, H; Zhou, S | 1 |
Buzaid, AC; da Câmera Lopes, LH; Hoff, PM; Moron, RA; Riechelmann, RP | 1 |
2 other study(ies) available for paclitaxel and Carcinoma, Acinar Cell
Article | Year |
---|---|
Efficacy of chemotherapy combined with toripalimab in PD-L1-positive and high tumor mutation burden pancreatic acinar cell carcinoma: case report.
Topics: Aged; Albumins; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Biomarkers, Tumor; Carcinoma, Acinar Cell; Deoxycytidine; Gemcitabine; Humans; Immunotherapy; Male; Mutation; Paclitaxel; Pancreatic Neoplasms | 2021 |
Acinar cell carcinoma of the pancreas.
Topics: Adult; Antineoplastic Agents, Phytogenic; Carcinoma, Acinar Cell; Disease-Free Survival; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Paclitaxel; Pancreatic Neoplasms; Treatment Outcome | 2003 |